Human trial success signals next stage of malaria vaccine development

Features
Initial success in human clinical trials has given hope for the next stage in the development of a new malaria vaccine. 
Published

$1.2 million in funding for Griffith disease research

Features
Griffith University research into fighting diseases of global impact are set to benefit from the latest National Health and Medical Research Council (NHMRC) 2018 Fellowship Program funding outcomes. Principal Research Leader Professor Suresh Mahalingam of the Institute for Glycomics has been successful in obtaining a Senior Research Fellowship B (SRFB) for the project “Arbovirus-Induced Inflammatory Disease: […]
Published
Australian Rivers Institute

Cheers – charge your glass with a Griffith scientist

Science will be on tap when researchers trade the lab for the pub.
Published
Griffith Enterprise

Institute for Glycomics shares in multi-million dollar grant for ground-breaking gonorrhoea research

The National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health (NIH), has announced awards to establish four Cooperative Research Centres (CRCs) which will focus on the development of vaccines to prevent sexually transmitted infections (STIs). The grants will support collaborative, multidisciplinary research on the pathogens that cause gonorrhoea, chlamydia […]
Published
Griffith Enterprise

Glycomics Circle – empowering women in science

The Institute for Glycomics recognises the value of having women in life sciences. For centuries women have made significant contributions to society, perfectly demonstrated by the fact that 51 women in total have been awarded the Nobel Prize between 1901 and 2018, twenty of which were awarded the Nobel Prize in the fields of physics, […]
Published
Griffith Enterprise

Malaria vaccine trial receives $500,000 in Government support

The Liberal National Government has announced they will donate $500,000 to Griffith University’s Institute for Glycomics to support their ongoing human clinical trials which aim to test the effectiveness of a world-first malaria vaccine candidate named PlasProtecT™. Malaria is caused by an infection with malaria parasites, and is generally characterised by fever, shivering headaches and […]
Published
Health

Institute for Glycomics joins peak body for medical research

Institute becomes member of Association of Australian Medical Research Institutes.
Published
Health

Mosquito-borne diseases: Griffith expert joins live Q&A

Academic offers insights into mosquito-borne diseases for live Q&A symposium.
Published
home

Governor-General visits Griffith for update on malaria vaccine trial

The Governor-General, His Excellency General the Honourable Sir Peter Cosgrove AK MC (Retd), got first-hand insights into the world’s first human clinical trials of a whole parasite blood-stage malaria vaccine when he visited the Institute for Glycomics. In what was one of his last duties before retiring in March, General Cosgrove was given a tour and updates on the […]
Published
Griffith Enterprise

Scientists make breakthrough in search for gonorrhoea vaccination

Public health problem takes on 'superbug' status
Published
Griffith Enterprise

Alzheimer’s drug may help battle antibiotic resistance

Drug originally proposed to treat Alzheimer’s disease has potential to combat dangerous antibiotic-resistant bacteria.
Published
Health

Griffith shares in $5 million for ground-breaking stroke research

A Griffith researcher has shared in a $5 million grant to develop ground-breaking research on stroke prevention. The Heart Foundation announced Professor Michael Good, from Griffith’s Institute for Glycomics, as one of the two Australian researchers who will share in the one-off grant open to researchers who could demonstrate they were working on innovative, internationally […]
Published
home

Hope for new blood test to detect early stage ovarian cancer

Potential to improve early detection of disease possible with new test.
Published
Griffith Enterprise

Researchers a step closer to understanding how deadly bird flu virus takes hold in humans

How highly pathogenic influenza viruses such as deadly bird flu infect humans is being unravelled. 
Published
Health

Development of a new class of antibiotics gives hope for treating multi-drug resistant bacteria

New type of antibiotic could limit multidrug resistance by targeting and disrupting key elements in bacterial cells.
Published
home

Glycomics Grand Ball Night to Take Centre Stage

It’s a night for support and appreciation of the ground-breaking work being carried out by Griffith University’s Institute for Glycomics and everyone is invited to be part of this special occasion. The Institute’s Grand Ball Night is regarded as a show-stopper each year with the 2018 edition promising to deliver a memorable evening full of […]
Published
home

Institute for Glycomics receives grant to go global with world-first drug

Institute for Glycomics receives Federal Government grant to partner with China to create world-first drug to treat Hand, Foot and Mouth Disease (HFMD).
Published
Alumni

Awards showcase outstanding Health alumni

From paediatric palliative care and humanitarian dental work to a passion for astrophysics and groundbreaking scientific research into Malaria, the 2018 Alumni Awards showcase the rich diversity of Griffith’s Health and Science alumni.
Published